|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- NOVEMBER 7, 2017: This month, Life Science Compliance Update has a SPECIAL ISSUE devoted to FOCUS ON THE PATIENT. To open the issue, we explore the critical issue of ACCESS TO MEDICINE and the growing impact of CORRUPTION and what the pharmaceutical industry can do to the help. Continuing the theme of access, we examine the changing environment around EXPANDED PATIENT ACCESS to INVESTIGATIONAL MEDICINESand the balancing act this causes for life science companies.
Next, we continue our series EXPANDING THE FRONTIER examining how companies should consider working with PATIENT ADVOCACY GROUPSand the impact of the latest ENFORCEMENT decisions in the AEGERIONcases. Finally, we round out this issue with a look at the latest TRANSPARENCY developments including new OPEN PAYMENTS data, new initiatives in SOUTH KOREA and CANADA, and finally the latest STATE and LOCAL government efforts to expand transparency requirements.
SPECIAL ISSUE: FOCUS ON THE PATIENT:
-
Why it matters -- Pharmaceutical compliance, Anti-corruption and Access to Medicine
Luca Genovese and Danny Edwards, The Access to Medicine Foundation
Topic tags: Access to Medicine • Corruption • Global • Patient Access
-
Increasing the Tension -- Expanding Patient Access to Investigational Medical Products
Maureen Lloyd a Health Industries, Risk and Regulatory Director and Dixil Francis a Health Industries, Risk and Regulatory Manager at PWC
Topic tags: Expanded Access • FDA • HIPPA • Investigational Products • Patient Access
-
The Expanding Frontier Part 2 -- Navigating the Complexity of Patient Advocacy Groups
Chad A. Morin, Senior Director Healthcare Compliance, bluebird bio
Topic tags: Disease awareness • Patient assistance programs • Sponsorships
-
The Expanding Frontier Part 3 -- PAGs in Light of the Aegerion Cases
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update
Topic tags: CIA • DPA • Enforcement • FDA • HIPPA • Off-label • Patient assistance programs • REMS
-
Transparency Perhaps a Falling Star in the U.S. But Rising Internationally
Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update
Topic tags: Canada • Open payments • South Korea • Transparency
-
Coming Soon to a State or Even City Near You -- Part 2 Spend Disclosure & Much More
Nicodemo (Nico) Fiorentino, Esq., Manager, Research & Compliance, for G&M Health LLC
Topic tags: California • Chicago • Discounts • Gift bans • Gifts • Maine • Nevada • New Jersey • Transparency
Thank you for relying on Life Science Compliance Update to keep you up-to-date on the pharmaceutical, biotechnology, and device manufacturing industries.
|
